Riskpilot← Back to searchSign inGet full accessMED Group A/S
A/SActiveCVR 45667340Virkelyst 1Activities of holding companies · NACE 6421Est. 2025— employees
Revenue 2025
DKK -15K
EBITDA margin
100.0%
Equity ratio
97.0%
Financial strength
Net profit 2025
DKK -18K
| Revenue | DKK -15K | — |
| EBITDA | DKK -15K | — |
| Net profit | DKK -18K | — |
| Total assets | DKK 15,7M | — |
| Equity | DKK 15,2M | — |
| Employees | — | — |
Legal name
MED Group A/S
CVR number
45667340
Legal form
Aktieselskab
NACE code
6421 · Activities of holding companies
Founded
6. juni 2025
Share capital
DKK 400.000
Employees
—
VAT registered
Yes
Audit selected
Yes
Last report
2025-09-30
Financial year
January – December
Signatory rights
Selskabet tegnes af den administrerende direktør i forening med bestyrelsesformanden eller af den samlede bestyrelse.
Company purpose
Selskabets formål er at fungere som moderselskab for MED koncernen og udøve ledelse, administration, finansiering og strategisk udvikling af koncernens datterselskaber.
Address
Virkelyst 1
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2025 |
|---|---|
| Revenue | -15 |
| Staff expenses | -0 |
| EBITDA | -15 |
| Depreciation & amort. | -0 |
| EBIT | -15 |
| Net financials | -8 |
| Profit before tax | -23 |
| Tax | -5 |
| Net profit | -18 |
| Item | 2025 |
|---|---|
| Total assets | 15.685 |
| Equity | 15.220 |
| Long-term debt | 0 |
| Short-term debt | 464 |
| Total debt | 464 |
EBITDA margin
-1500000.0%
This company
15.8%
Market median
-9493771% vs market
20252025
Equity ratio
97.0%
This company
38.2%
Market median
+154% vs market
20252025
Return on equity
-0.1%
This company
18.4%
Market median
-101% vs market
20252025
Net profit margin
-1758900.0%
This company
8.1%
Market median
-21714915% vs market
20252025
Asset turnover
-0.00×
This company
1.12×
Market median
-100% vs market
20252025
Debt / equity
0.03×
This company
0.62×
Market median
+95% vs market
20252025
- Annual report 2025Filed via CVR / Virk · Period 2025-06-06 – 2025-09-30
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
PM Chief Executive Officer | Chief Executive Officer | 2025 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2025 | — | — | |
| Chairman | 2025 | — | — | |
| Board of Directors | 2025 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Skjold Gruppen ApS | Company | 66.7% | 66.7% | 2025 |
TTK Holding ApS | Company | 10.0% | 10.0% | 2025 |
MHMJ Holding ApS | Company | 10.0% | 10.0% | 2025 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Skjold Jensen Holding ApS
MED Group A/S Board members of MED Group A/S also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Peter Martin Skjold Jensen | Chief Executive Officer | 0 companies |
| Birgitte Grabow Westergaard | Board of Directors | 0 companies |
| Maud Transbøl | Chairman | 0 companies |
| Peter Dahl Thruelsen | Board of Directors | 0 companies |